Rchr
J-GLOBAL ID：200901082718821619   Update date: Jan. 11, 2023

Suzuki Kazuhiro

スズキ カズヒロ | Suzuki Kazuhiro
Affiliation and department：
Gunma University

About Gunma University


Job title： Professor
Research field  (1)： Urology
Research keywords  (2)： 前立腺癌 ,  前立腺癌
Papers (318)：
  • Yoshiyuki Miyazawa, Takanori Shimizu, Yoshitaka Sekine, Seiji Arai, Akira Ohtsu, Yuji Fujizuka, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Kazuhiro Suzuki. Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin. IJU case reports. 2023. 6. 1. 37-40
  • Hiroji Uemura, Kazuki Kobayashi, Akira Yokomizo, Shiro Hinotsu, Shigeo Horie, Yoshiyuki Kakehi, Norio Nonomura, Osamu Ogawa, Mototsugu Oya, Kazuhiro Suzuki, et al. Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study. International journal of clinical oncology. 2022
  • Akira Ohtsu, Seiji Arai, Tatsuhiro Sawada, Mai Kato, Yuta Maeno, Yoshiyuki Miyazawa, Yuji Fujizuka, Yoshitaka Sekine, Hidekazu Koike, Hiroshi Matsui, et al. Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells. Biochemical and Biophysical Research Communications. 2022
  • 新井 誠二, 宮澤 慶行, 大津 晃, 澤田 達宏, 関根 芳岳, 柴田 康博, 鈴木 和浩. 【前立腺癌を対象にした最新の基礎研究-トランスレーショナルリサーチによる未来予想図-】前立腺癌における血中・組織ステロイドの代謝と薬剤感受性. Prostate Journal. 2022. 9. 1. 35-40
  • Hiroshi Nakayama, Yoshitaka Sekine, Daisuke Oka, Yoshiyuki Miyazawa, Seiji Arai, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuhiro Suzuki. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer. The Prostate. 2022. 82. 3. 314-322
ｍore...
MISC (640)：
  • Akira Ohtsu, Seiji Arai, Tatsuhiro Sawada, Kazuhiro Suzuki. Protein translation inhibitor homoharringtonine prevents androgen receptor-positive prostate cancer cell growth. CANCER SCIENCE. 2022. 113. 1731-1731
  • Akira Ohtsu, Seiji Arai, Tatsuhiro Sawada, Kazuhiro Suzuki. Erdafitinib in combination with BCLXL/BCL2 inhibitor induce apoptosis in urothelial carcinoma cells without FGFR mutation. CANCER RESEARCH. 2021. 81. 13
  • Seiji Arai, Akira Ohtsu, Tatsuhiro Sawada, Kazuhiro Suzuki. Mitochondria E3 Ubiquitin Ligase MARCH5 Mediates Stress-Induced and NOXA-Dependent MCL1 Degradation. CANCER SCIENCE. 2021. 112. 329-329
  • Akira Ohtsu, Seiji Arai, Tatsuhiro Sawada, Kazuhiro Suzuki. MCL1 inhibitor drives prostate cancer cell apoptosis in combination with mitochondria-targeting drugs. CANCER SCIENCE. 2021. 112. 668-668
  • 鈴木和浩, 周東孝浩, 宮澤慶行, 新井誠二, 関根芳岳. Cardiovascular disease and androgen deprivation therapy for prostate cancer. 月刊泌尿器科. 2021. 13. 4
ｍore...
Patents (1)：
  • 前立腺癌と良性前立腺過形成の鑑別法
Books (10)：
  • 去勢抵抗性前立腺がん 薬物治療UPDATE
    先端医学社 2015
  • 癌と骨
    メデイカルレビュー社 2013
  • がん骨転移のバイオロジーとマネージメント:がん治療による骨量減少(CTIBL)
    医薬ジャーナル 2012
  • 前立腺癌診療ガイドライン2012年版 疫学
    金原出版 2012
  • 前立腺癌
    今日の診断指針第6版 2011
ｍore...
Lectures and oral presentations  (96)：
  • Effects of LH-RH agonist on hormonal and cognitive function of prostate cancer patients in relation to testicular and adrenal androgens.
    (15th International Congress on Hormonal Steroids and Hormones & Cancer symposium 2012)
  • Impact of pre-treatment prostate tissue androgen content on the prediciton of future castration-resistant prostate cancer development in patients treated with primary androgen deprivation therapy.
    (15th International Congress on Hormonal Steroids and Hormones & Cancer 2012)
  • Evaluation of adrenal androgens and estrogen levels in the prostatic tissue with prostate cancer or benign prostatic hyperplasia.
    (15th International Congress on Hormonal Steroids and Hormones & Cancer 2012)
  • Androgen production in periprostatic adipose tissue in prostate cancer patients.
    (27th Annual EAU Congress 2012)
  • High-fat diet increased leptin, and the antitumor sensitization effect due to survivin inhibition in simvastatin treatment for renal cancer.
    (27th Annual EAU Congress 2012)
ｍore...
Education (3)：
  • - 1996 Gunma University
  • - 1996 Gunma University Graduate School, Division of Medicine
  • - 1988 Gunma University Faculty of Medicine
Professional career (1)：
  • (BLANK) (Gunma University)
Work history (2)：
  • 1997 - 1999 The Ohio State University
  • 1997 - 1999 Post-doctoral fellow, Hematology/Oncology, OHIO STATE UMV
Committee career (19)：
  • 日本内分泌学会 代議員
  • 日本ステロイドホルモン学会 評議員
  • 日本泌尿器科学会 評議員
  • 日本癌治療学会 評議員
  • 日本アンドロロジー学会 評議員 監事
Show all
Awards (2)：
  • 2002 - 前立腺がんワークショップ医学賞
  • 1997 - 第1回北関東医学会奨励賞
Association Membership(s) (16)：
American Society of Clinical Oncoogy ,  Europen Society of Medical Oncology ,  日本内分泌学会 ,  日本ステロイドホルモン学会 ,  日本家族性腫瘍学会 ,  日本泌尿器科学会 ,  日本癌治療学会 ,  日本アンドロロジー学会 ,  日本がん検診・診断学会 ,  日本透析医学会 ,  北関東医学会 ,  American Urological Association ,  American Association for Cancer Research ,  International Society of Urology ,  American Society of Clinical Oncoogy ,  Europen Society of Medical Oncology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM